The 2-week wait for suspected cancer: Time for a rethink?

International Journal of Clinical Practice

Volumn 59, Issue 11, 2005, Pages 1334-1339

  Hanna, S J ^a   Muneer, A ^a   Khalil, K H ^a  

^a NORTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

2 Week rule; Cancer; Oncology service; Waiting lists

Indexed keywords

BRAIN CANCER; BREAST CANCER; CANCER SCREENING; CANCER SURVIVAL; CLINICAL ASSESSMENT; CLINICAL TRIAL; COCHRANE LIBRARY; CONSULTATION; DIAGNOSTIC ACCURACY; DIGESTIVE SYSTEM CANCER; EARLY DIAGNOSIS; GENERAL PRACTITIONER; GYNECOLOGIC CANCER; HEAD AND NECK CANCER; HEALTH CARE ACCESS; HEMATOLOGIC MALIGNANCY; HUMAN; INFORMATION RETRIEVAL; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; MEDICAL AUDIT; MEDICAL INFORMATION; MEDICAL SPECIALIST; MEDLINE; PATIENT EDUCATION; PATIENT REFERRAL; PATIENT SCHEDULING; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RETROSPECTIVE STUDY; REVIEW; SKIN CANCER; THORAX RADIOGRAPHY; UNITED KINGDOM; URINARY TRACT CANCER; FEMALE; HOSPITAL ADMISSION; MALE; NATIONAL HEALTH SERVICE; NEOPLASM; PSYCHOLOGICAL ASPECT; STANDARD; TIME;

FEMALE; GREAT BRITAIN; HUMANS; MALE; NEOPLASMS; REFERRAL AND CONSULTATION; STATE MEDICINE; TIME FACTORS; WAITING LISTS;

EID: 33644877380     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1368-5031.2005.00687.x     Document Type: Review

References (45)

1. The EUROCARE-2 Study. Survival of Cancer Patients in Europe Lyon: IARC Scientific Publicatiions, 1999: 1-572.
2. Jones R, Rubin G, Hungin P. Is the two week rule for cancer referrals working? BMJ 2001; 322: 1555-6.
3. Department of Health. The NHS, Cancer Plan London: The Stationery Office Ltd, 2000.
4. Cant PJ, Yu DSL. Impact of the '2 week wait' directive for suspected cancer on service provision in a symptomatic breast clinic. Br J Surg 2000; 87: 1082-6.
5. Khawaja AR, Allan SM. Has the breast cancer 'two week wait' guarantee for assessment made any difference? Eur J Surg Oncol 2000; 26: 536-9.
6. Khawaja AR, Allan SM. Audit of referral practice to a fast-access breast clinic before the guaranteed 2-week wait. Ann R Coll Surg Engl 2001; 83: 58-60.
7. Campbell L, Prance S, Teasdale C, Watkins RM. The 'two-week wait' for suspected breast cancer; its impact on a symptomatic breast unit and correlation of referrals with outcome. Br J Surg 2000; 87 (Suppl. 1): 37 (Abstract) Breast 005.
8. Sauven P. Impact of the '2 week wait' on referrals to breast units in the UK. Breast 2002; 11: 262-4.
9. Pengiran Tengah DSNA, Byrne PO, Wills AJ. Urgent 2-week referrals for CNS/brain tumours: A retrospective audit. Clin Oncol 2003; 15: 7-9.
10. Oliver MD. All stages of care pathway need speeding up. BMJ 2001; 323: 864.
11. Maruthacalam K, Noblett SE, Chaudri S, Stoker E, Horgan AF. Two week rule cancer referral: Direct access colonoscopy vs outpatient appointment -a prospective audit and satisfaction survey. Colorectal Dis 2004; 6 (Suppl. 1): 49.
12. Duff SE, Wood C, McCredie V, Levine E. Waiting times for treatment of rectal cancer in North West England. J R Soc Med 2004; 97: 117-9.
13. Soo FY, Winterton R, Plusa SM. Impact of the '2 week rule' on the treatment of colorectal cancer. Gut 2001; 48 (Suppl. 1): A53.
14. Walsh S, Bruce C, Bennington S, Ravi S. The fourteen-day rule and colorectal cancer. Ann R Coll Surg Engl 2002; 84: 386-8.
15. Flashman K, O'Leary DP, Senapati A, Thompson MR. The Department of Health's 'two week standard' for bowel cancer: Is it working? Gut 2004; 53: 387-91.
16. Heriot AG, Chappell B, Richardson S, Cripps NP, Simson JN. A prospective study of the effect of the implementation of the 2-week rule for colorectal cancer referral in a District General Hospital. Colorectal Dis 2001; 3 (Suppl. 1): PO14.
17. Hagger R, Ahmed W, Scott H, Beam P, Donaldson D. Audit of the introduction of a 'two week rule' scheme for colorectal cancer to a district general hospital. Colorectal Dis 2001; 3 (Suppl. 1): PO15.
18. Makin EC, Scott AND, Jameson JS, Loftus IM. Most gastrointestinal cancers are diagnosed outside of the '2-week wait' referral guidelines. Br J Surg 2002; 89 (Suppl. 1): A06.
19. Debnath D, Dielehner N, Gunning KA. Guidelines, compliance, and effectiveness: A 12 months' audit in an acute district general healthcare trust on the two week rule for suspected colorectal cancer. Postgrad Med J 2002; 78: 748-51.
20. Eccersley AJ, Wilson EM, Makris A, Novell JR. Referral guidelines for colorectal cancer - do they work? Ann R Coll Surg Engl 2003; 85: 107-10.
21. Adeosun BA, Wright J, Ross AHM, Richardson NGB. A 2-week referral service for colorectal cancer has little impact on existing activity in the first year. Colorectal Dis 2002; 4 (Suppl. 1): P030.
22. Vieten D, Carney LJ, Hollowood A, Dixon AR. The 2-week referral pathway for colorectal cancer - potential to miss serious disease. Colorectal Dis 2002; 4 (Suppl. 1): PO29.
23. MacDonald L, Mitchell SJ, Chadwick MA, Roe AM. Two-week wait colorectal cancer clinics: A prospective analysis of appropriateness of referral. Colorectal Dis 2002; 4 (Suppl. 1): P021.
24. Gandy CP, Morrell V, Pullan R, DeFriend D. Does the two-week rule for colorectal cancer provide benefit for patients? Colorectal Dis 2002; 4 (Suppl. 1): P022.
25. Barwick TW, Scott SB, Ambrose NS. The two week referral for colorectal cancer: A retrospective analysis. Colorectal Dis 2004; 6: 85-91.
26. Davies RJ, Welbourn R, Collins C, Kennedy R, Royle C. A prospective study to assess the implementation of a fast-track system to meet the two-week wait target for colorectal cancer. Gut 2001; 48 (Suppl. 1): A53.
27. Davies RJ, Collins CD, Eyre-Brook I, Vickery CJ, Welbourn R. A prospective observational study over three years to assess the impact of the two-week target on emergency admissions with colorectal cancer. Br J Surg 2003; 90 (Suppl. 1): 132.
28. Logan RFA, Behan MWH, Campion G, Keating NA. Impact of the two-week referral guideline on time to diagnosis and treatment in oesophago-gastric cancer. Clin Med 2003; 3: 386-7.
29. Moreea S, Green J, MacFie J, Mitchell CJ. Impact of the two week waiting time standard on the gastroenterology service of a district general hospital. Gut 2001; 48 (Suppl. 1): A3.
30. Boulton-Jones JR, Gamble S, Robinson MH, Goddard WP, Long RG, Teahon K. The impact of the two-week wait scheme for suspected gastrointestinal cancers. Clin Med 2003; 3: 483-4.
31. Martin JP, Gabe SM, Pitcher MCL, Jacyna MR. Referral patterns to a district general hospital gastroenterology outpatient clinic: implications for the 'two-week target'. Int J Clin Pract 2002; 56: 26-8.
32. Gilliam AD, Lobo DN, Rowlands BJ, Beckingham IJ. The 'two-week' target for the diagnosis of pancreatic carcinoma: An achievable aim? Eur J Surg Oncol 2002; 29: 575-9.
33. Morrison J, Gillespie S, MacKenzzie IZ. 'Two week wait' standards for suspected gynaecological malignancy. On target, but missing the point? J Br Menopause Soc 2003; 9: 170-2.
34. Patch SM, Smith SR, Rymes N, Turner D. Impact of the two week wait initiative on referral patterns for haematological malignancies in South Devon. Br J Haematol 2003; 121 (Suppl. 1): 16.
35. Lyons M, Philpott J, Hore I, Watters G. Audit of referrals for head and neck cancer -the effect of the 2-week, fast track referral system. Clin Otolaryngol 2004; 29: 143-5.
36. Williams RW, Hughes W, Felmingham S, Irvine GH. An audit of two week wait referrals for head and neck cancer. Ann R Coll Surg Engl Suppl 2002; 84: 304-6.
37. Dobson L, Halpin DMG, Sheldon CD, Withers NJ. Experience from the first 24 months of a fast track lung cancer clinic. Thorax 2002; 57 (Suppl. 3): P65 [Poster 61].
38. Heinink RA, Moudgil H. Appropriateness of referral patterns under the two week rule for lung cancer. Thorax 2002; 57 (Suppl. 3): P65 [Poster 62].
39. Cox NH. Evaluation of the UK 2-week referral rule for skin cancer. Br J Dermatol 2004; 150: 291-8.
40. Allen D, Popert R, O'Brien T. The two-week-wait cancer initiative in urology: Useful modernisation? J R Soc Med 2004; 97: 279-81.
41. Coxon JP, Harris HJ, Watkin NA. A prospective audit of the implementation of the 2-week rule for assessment of suspected urological cancers. Ann R Coll Surg Engl 2003; 85: 347-50.
42. MacDonald J. Biological predeterminism in human cancer. Surg Gynecol Obstet 1951; 92: 443-52.
43. Malik AI, Tou S, Huang A. Waiting times for cancer treatment. J R Soc Med 2004; 97: 311.
44. Jones R. Quick quick slow. HSJ 2001; 111: 20-3.
45. Thomas SJ, Williams MV, Burnet NG, Baker CR. How much surplus capacity is required to maintain low waiting times? Clin Oncol 2001; 13: 24-8.